Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the company has expanded the Executive Committee to prepare for multiple upcoming new product launches.

Effective January 1, 2023, Juan Andres will step into a new role as President, Strategic Partnerships and Enterprise Expansion, and will focus on building out the organization to support the growing pipeline. In this role, he will continue to serve on the Executive Committee and report to Mr. Bancel.

Dr. Jerh Collins, Ph.D. will join the company as Chief Technical Operations and Quality Officer, succeeding Mr. Andres. Dr. Collins will join Moderna on October 3, 2022 and will assume the role of Chief Technical Operations and Quality Officer on January 1, 2023. Dr. Collins will serve on Moderna's Executive Committee and report to Chief Executive Officer, Stéphane Bancel.

"Juan Andres has been an incredible partner in leading Moderna's manufacturing operations over the last several years, and he has played a crucial role in our COVID-19 vaccine production efforts, protecting and saving hundreds of millions of lives," said Moderna Chief Executive Officer Stéphane Bancel. "I am very pleased that Juan will apply his leadership and experience to allow Moderna to scale in its next phase of growth. Juan's continued leadership will be critical as we prepare for several upcoming new product launches."

"At the same time, we are incredibly excited to have Jerh Collins joining the Moderna team to succeed Juan as the company's next Chief Technical Operations and Quality Officer," Bancel continued. "Jerh joins Moderna with three decades of experience in global pharmaceutical manufacturing roles, including managing several manufacturing plants and as a Site Head. I'm confident that Jerh possesses the mindset and experience to expand our production footprint as we grow globally and internalize more of our production capabilities."

Dr. Collins joins Moderna from Novartis, where for the last nearly 30 years he had roles of increasing responsibility focused on pharmaceutical production and manufacturing, including roles serving as Head of Global Chemical Operations and Anti-Infectives and as Head of Global Chemical Operations. Dr. Collins received his Bachelor of Science in Chemistry and his Ph.D. in Organic Chemistry from University College Cork, Ireland. He also conducted post-doctoral cancer research at Arizona State University.

"I'm incredibly excited to join Moderna, an organization that I have watched quickly scale technological and scientific breakthroughs for the benefit of people all around the world," said Dr. Collins. "It's a company that is redefining the future of medicine. I've also had the privilege of knowing and working with Juan for many years, and I am honored to continue his steady leadership of this team."